Clinical Drug Experience Knowledgebase

Carcinoma (Phase 1)

Carcinoma, Merkel Cell (Phase 1)

Carcinoma, Non-Small-Cell Lung (Phase 1)

Communicable Diseases (Phase 2)

Coronaviridae Infections (Phase 2)

Coronavirus Infections (Phase 2)

Herpes Genitalis (Phase 2)

Herpes Zoster (Phase 1)

Immune System Diseases (Phase 2)

Infections (Phase 2)

Influenza, Human (Phase 1)

Influenza in Birds (Phase 1)

Leishmaniasis (Phase 2)

Leishmaniasis, Cutaneous (Phase 2)

Leishmaniasis, Mucocutaneous (Phase 1)

Leishmaniasis, Visceral (Phase 1)

Leprosy (Phase 2)

Liposarcoma (Phase 2)

Liposarcoma, Myxoid (Phase 2)

Lung Diseases (Phase 2)

Lymphoma (Phase 2)

Lymphoma, Follicular (Phase 2)

Lymphoma, Non-Hodgkin (Phase 2)

Malaria (Phase 1)

Malaria, Falciparum (Phase 1)

Melanoma (Phase 1)

Neoplasm Metastasis (Phase 1)

Neoplasms (Phase 2)

Nidovirales Infections (Phase 2)

Ovarian Neoplasms (Phase 1)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Respiratory Tract Diseases (Phase 2)

Respiratory Tract Infections (Phase 2)

RNA Virus Infections (Phase 2)

Sarcoma (Phase 3)

Sarcoma, Synovial (Phase 3)

Schistosomiasis (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Triple Negative Breast Neoplasms (Phase 2)

Tuberculosis (Phase 2)

Tuberculosis, Pulmonary (Phase 1)

Virus Diseases (Phase 2)